Latest Breaking News On - கடுமையானது ஒவ்வாமை - Page 1 : comparemela.com

Mumbai (Maharashtra) [India], May 3 (ANI/PRNewswire): Glenmark Pharmaceuticals Limited, a research-led, global integrated pharmaceutical company, announced the launch of Ryaltris®-AZ Nasal Spray for the treatment of moderate to severe allergic rhinitis, in India. Glenmark being one of the leaders in respiratory segment, has been the first to launch the branded generic version at an affordable cost for the treatment of allergic rhinitis in India. This will provide patients a far more convenient, cost-effective treatment option in the country. Glenmark is the first company in the world to launch Ryaltris®-AZ, as a novel fixed dose combination of Mometasone furoate 50 mcg + Azelastine 140 mcg.

Glenmark ryaltrisAlok malikGroup viceGlenmark pharmaceuticalsGlenmark pharmaceuticals limitedGroup vice presidentBusiness headIndia formulationsAllergic rhinitisIntranasal corticosteroidIntranasal antihistamineSevere allergicAlok malikAllergic rhinitisஅலோக் மாலிக்குழு துணை